Optimizing multiple myeloma treatment Jesús San Miguel, MD, PhD, University of Navarra Clinic, Pamplona, Spain, talks on the importance of having access to optimal tools, such as measurable …

Daratumumab in the treatment of multiple myeloma Paul Richardson, MD, from the Dana-Farber Cancer Institute, Boston, MA, discusses the use of daratumumab in the treatment of multiple myeloma at the 2017 British Society for Haematology (BSH) Annual Scientific Meeting in Brighton, UK. Daratumumab is the frontline in monoclonal antibody treatment in multiple myeloma. It is […]

Novel therapeutics in multiple myeloma There are currently many exciting novel therapeutics and combination therapies undergoing clinical trials for use in multiple myeloma (MM) patients. These are explored in an intriguing panel discussion by Thomas Martin, MD from UCSF School of Medicine, San Francisco, CA, Larry Boise, PhD from Emory University School of Medicine, Atlanta, […]

Multiple Myeloma Diagnosis and Treatment 😍🖼Animated Mnemonics (Picmonic): https://www.picmonic.com/viphookup/medicosis/ – With Picmonic, get your life back by studying less and remembering more. Medical and Nursing students say that Picmonic is the most comprehensive and effective way to bridge learning and test prep… Disclaimer: I use affiliate links…. ►👨‍🏫💊Antibiotics Lectures: https://www.medicosisperfectionalis.com/products/courses/antibiotics/ … Check out my brand […]

Know What Your Doctors Know: Multiple Myeloma Part 8 – Side Effects of Treatment Experts discussed updates in the treatment of multiple myeloma during live webinars hosted by the National Comprehensive Cancer Network (NCCN) on April 15 and 16, 2019.

Pursue 8 E (Live): Nephropathology- Plasma cell Dyscrasia. Nephropathology Plasma cell Dyscrasia. Lecture conducted by: Dr. Suvradeep Mitra MD. (PGIMER- Chandigarh), DM- Histopathology (PGIMER- Chandigarh) PDCC (ICP) in Renal and Transplant Pathology (PGIMER, Chandigarh). Asst Professor in the Dept of Pathology and Lab Medicine, AIIMS, Bhubaneswar More than 70 publications in indexed National and International […]

Relapsed/Refractory Multiple Myeloma: Optimal Therapy Optimal treatment approaches and considerations for sequencing therapy in patients with relapsed/refractory multiple myeloma.

Advances in Blood Cancers: Update on Myeloma- Diagnosis Learn more about diagnosis from three myeloma clinicians, including interviews with three myeloma survivors. To watch additional patient education videos, please visit https://www.LLS.org/educationvideos Support for this video provided by Bristol –Myers Squibb, Celgene Corporation, ONYX Pharmaceuticals, Inc. an Amgen subsidiary, and Takeda Pharmaceutical Company Ltd.

Treatment at first relapse in multiple myeloma: how to choose a drug? Gareth Morgan, MD, FRCP, FRCPath, PhD from the UAMS Myeloma Institute, Little Rock, AR provides an overview of his talk on ‘Treatment strategies at first relapse’ held at the European Hematology Association (EHA) 2016 Annual Congress in Copenhagen, Denmark. Prof. Morgan discusses why […]

What is the best way to manage multiple myeloma in the era of COVID-19? This IMF Patient and Family Webinar will focus on “Best Myeloma Management in the Era of COVID – 19” IMF Chairman Dr. Brian G.M. Durie will moderate presentations with a panel of myeloma experts. What to Expect : In this webinar, […]